-
-
7 . Periodical
A Phase 2a Open-Label Study to Investigate Safety and Tolerability (including the MTD), Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of MT-3724 in Combination with Lenalidomide in Subjects with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
- 저자
- by Burnett, Christine; Gordon, Gary; Strack, Thomas; Lehner, Tara; Higgins, Jack P, et al.
- 소스
- Blood; November 2019, Vol. 134 Issue: Supplement 1 p1597-1597, 1p